Manufacturing BMS banks on Texas for $2.3bn multi-modal manufacturing facility Pharmaceutical TechnologyThis will establish BMS' in-house manufacturing presence in Texas, adding to its ongoing outlicensing and research partnerships in the state.Read full story pharminent August 11, 2026 (Last updated: August 11, 2026) Pharmaceutical Technology This will establish BMS’ in-house manufacturing presence in Texas, adding to its ongoing outlicensing and research partnerships in the state. Read full story Post navigation Previous: Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfrontNext: UK regulators greenlight Lilly’s Foundayo, intensifying Novo competition Related Stories Manufacturing Samsung Biologics inks $262M manufacturing deal with European pharma company pharminent September 11, 2026 Manufacturing Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision pharminent September 9, 2026 Manufacturing US puts $125m into personalised RNA therapy production pharminent September 2, 2026